pharmacopeia

Mechanism of action

Sourced from openFDA

Mechanism-of-action classes: Chloride Channel Antagonists; Enzyme Inhibitors.

Chloride ChannelEnzyme

Indications

Sourced from openFDA
  • Use treats head liceICD-10: B85.0

Dosage & administration

Sourced from openFDA

Directions Inspect • all household members should be checked by another person for lice and/or nits (eggs) • use a magnifying glass in bright light to help you see the lice and nits (eggs) • use a tool, such as a comb or two unsharpened pencils to lift and part the hair • look for tiny nits near the scalp, beginning at the back of the neck and behind the ears • small sections of hair (1-2 inches wide) should be examined at a time • unlike dandruff, nits stick to the hair. Dandruff should move when lightly touched. • if either lice or nits (eggs) are found, treat with the creme rinse Treat • wash hair with a shampoo without conditioner. Do not use a shampoo that contains a conditioner or a conditioner alone since this may decrease the activity of the creme rinse. Rinse with water. • towel dry hair so it is damp but not wet • shake the bottle well • completely saturate the hair and scalp with the creme rinse. Begin to apply the creme rinse behind the ears and at the back of the neck. • keep the creme rinse out of the eyes. Protect the eyes with a washcloth or towel. • leave the creme rinse on the hair for 10 minutes, but no longer • rinse with warm water • towel dry hair and comb out tangles • if live lice are seen seven days or more after the first treatment, a second treatment should be given Remove Lice/Nits • remove nits by combing the hair with the special small tooth comb provided. Remaining nits may be removed by hand (using a throw-away glove), or cutting the nits out.

Warnings & precautions

Sourced from openFDA

For external use only Do not use • on children under 2 months of age • near the eyes • inside the nose, ear, mouth, or vagina • on lice in eyebrows or eyelashes. See your doctor. Ask a doctor before use if you are • allergic to ragweed. May cause breathing difficulty or an asthmatic episode. When using this product • keep eyes tightly closed and protect eyes with a washcloth or towel • if product gets into the eyes, immediately flush with large amounts of water • scalp itching or redness may occur Stop use and see a doctor if • breathing difficulty occurs • eye irritation occurs • skin or scalp irritation continues or infection occurs If pregnant or breast-feeding, ask a health professional before use. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. (1-800-222-1222)

Approval history

Sourced from openFDA
  • Aug 25, 1989NDANDA019855Aurobindo Pharma Usa
  • May 2, 1990NDANDA019918Medtech Products
  • Jan 23, 1998ANDAANDA074806Actavis Labs
  • Dec 20, 2001ANDAANDA076090Perrigo New York
  • Apr 21, 2003ANDAANDA076369Padagis Israel
  • Apr 3, 2019ANDAANDA211303Encube Ethicals

FAERS reports

View JSON
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. Counts reflect reporting volume — how often a reaction was reported, not how often it occurs. For decision-grade use, consult openFDA and the FAERS Public Dashboard directly.
1,720 total reports matchedLatest report Share = reports listing the reaction ÷ total matched reports. Rows can sum to >100% because a single report often lists multiple reactions.
  1. 1Drug Ineffective34920%
  2. 2Pruritus1418.2%
  3. 3Off Label Use1106.4%
  4. 4Pain925.3%
  5. 5Rash794.6%
  6. 6Nausea764.4%
  7. 7Headache754.4%
  8. 8Dry Skin714.1%
  9. 9Alopecia694.0%
  10. 10Anxiety694.0%
  11. 11Chronic Kidney Disease673.9%
  12. 12Diarrhoea543.1%
  13. 13Fatigue533.1%
  14. 14Inappropriate Schedule Of Product Administration523.0%
  15. 15Product Use In Unapproved Indication502.9%

Literature

View JSON

Recent PubMed references pinned to Permethrin as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

Clinical trials

View JSON

The 10 most recently updated of 64 ClinicalTrials.gov registrations naming Permethrin as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

Frequently asked questions

How does Permethrin work?
Mechanism-of-action classes: Chloride Channel Antagonists; Enzyme Inhibitors.
What is Permethrin used for?
According to FDA labeling, Permethrin carries indications including: Use treats head lice. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.
What class of drug is Permethrin?
Permethrin is classified as Pyrethrines, incl. synthetic compounds, Pyrethroid, Chloride Channel Antagonists, Enzyme Inhibitors, Decreased Striated Muscle Organized Electrical Activity.
What are the brand names for Permethrin?
Permethrin is marketed under brand names including Acticin, Elimite, Nix Cream Rinse.
Note. Data for permethrin is illustrative MVP content compiled from public sources. pharmacopeia is for educational and informational use only and is not a substitute for professional medical advice.

Search pharmacopeia

Search drugs, classes, and ingredients